Omacetaxine Mepesuccinate

Category: Cancer



Omacetaxine Mepesuccinate Overview

Omacetaxine mepesuccinate (INN, trade names Synribo or Myelostat ), formerly named as homoharringtonine or HHT, is a pharmaceutical drug substance that is indicated for treatment of chronic myeloid leukemia (CML). It is a natural product first discovered in Cephalotaxus harringtonii, now manufactured by hemi-synthesis. It was approved by the US FDA in October 2012 for the treatment of adult patients with CML with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs).[...

Read more Omacetaxine Mepesuccinate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Omacetaxine_mepesuccinate

Recent Omacetaxine Mepesuccinate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Omacetaxine Mepesuccinate
  • Injection: 3.5mg/vial
  • Powder: 3.5mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Omacetaxine Mepesuccinate or a similar ingredient: (1 result)

  • Synribo Omacetaxine Mepesuccinate




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2018 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 18 August 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.